ANAPTYSBIO, INC. Deferred Tax Liabilities, Property, Plant and Equipment
ANAPTYSBIO, INC. (ANAB) had Deferred Tax Liabilities, Property, Plant and Equipment of $163.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2025-02-27
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $163.00K.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $122.00K.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $189.00K.
- 2021-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $115.00K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2024-12-31 | $163.00K 10-K · filed 2025-02-27 |
| 2023-12-31 | $122.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $189.00K 10-K · filed 2024-03-11 |
| 2021-12-31 | $115.00K 10-K · filed 2023-03-01 |
| 2020-12-31 | $150.00K 10-K · filed 2022-03-07 |
| 2019-12-31 | $349.00K 10-K · filed 2021-02-25 |
| 2018-12-31 | $49.00K 10-K · filed 2020-03-02 |
| 2017-12-31 | $57.00K 10-K · filed 2019-02-28 |
| 2016-12-31 | $108.00K 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |